Leaflet VACCIN COMBINAT DIFTERO-TETANO-PERTUSSIS ADSORBIT (VCDTP) DT 30 Lf / ml TT 12 UB / ml B.pert injection suspension

Indicated for: prevention of diphtheria, tetanus and pertussis

Route of administration: injectable

Substance: diphtheria + tetanus vaccine + cellular pertussis (vaccine)

ATC: J07AJ51 (Antiinfectives for systemic use | Bacterial vaccines | Pertussis vaccines)

Precautions:
Anaphylaxis
Anaphylaxis

Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.

Additional monitoring
Additional monitoring

This medicine is subject to additional monitoring.

Refrigerated storage
Refrigerated storage

Store in the refrigerator as instructed in the leaflet.

Protect from light
Protect from light

Store protected from light.

The diphtheria, tetanus, whole-cell pertussis (DTPc) vaccine is used to prevent diphtheria, tetanus, and whooping cough (pertussis), three serious infectious diseases caused by bacteria. The vaccine contains diphtheria and tetanus toxoids, as well as inactivated whole cells of Bordetella pertussis, which stimulate the immune system to produce specific antibodies against these pathogens.

The vaccine is administered intramuscularly, usually in multiple doses, according to recommended vaccination schedules for infants and young children. Booster doses are required at regular intervals to maintain immunity.

Common side effects include pain at the injection site, mild fever, fatigue, and irritability. In rare cases, severe allergic reactions may occur.

The DTPc vaccine is an essential measure for protecting public health, helping to reduce the incidence and severity of these infectious diseases and prevent the severe complications associated with them.

General data about VACCIN COMBINAT DIFTERO-TETANO-PERTUSSIS ADSORBIT (VCDTP) DT 30 Lf / ml TT 12 UB / ml B.pert

  • Substance: diphtheria + tetanus vaccine + cellular pertussis
  • Date of latest medicines list: 01-07-2013
  • Product code: W13382001
  • Concentration: DT 30 Lf / ml TT 12 UB / ml B.pert
  • Pharmaceutical form: injection suspension
  • Quantity: 50
  • Product type: Generic medicine
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Concentrations available for diphtheria + tetanus vaccine + cellular pertussis

  • 0.5ml/dose
  • DT 30 Lf/ml TT 12 UB/ml B.pert